Search clinical trials for: Recombinant Botulinum Toxin Type A, Glabellar Lines

Total 68132 results

JHM BioPharma (Tonghua) Co. , Ltd.

Recruiting

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Chongqing Claruvis Pharmaceutical Co., Ltd.

Completed

A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
AbbVie

Recruiting

A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines

Upper Facial Lines

United States, Canada
Protox Inc.

Not yet recruiting

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines
Hugel

Recruiting

Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Lines

Korea, Republic of
ATGC Co., Ltd.

Recruiting

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Glabellar Frown Lines

Korea, Republic of
Clinical Testing of Beverly Hills
Allergan

Recruiting

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Merz North America, Inc.
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines (ULTRA I)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

United States
Henry Ford Health System

Active, not recruiting

Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Medy-Tox

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Glabellar Frown Lines

Australia
Galderma R&D

Completed

Study Comparing Treatment With Alluzience vs Reconstituted Toxin (STAR)

Glabellar Frown Lines

Germany, United Kingdom
Protox Inc.

Completed

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Merz Aesthetics GmbH
Merz Pharmaceuticals GmbH

Completed

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Moderate to Severe Glabellar Frown Lines

United States, Germany
Allergan

Completed

A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Glabellar Lines

United States
Galderma R&D

Completed

A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Evolus, Inc.
ethica Clinical Research Inc.

Completed

Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines

Glabellar Frown Lines

United States
Huons Co., Ltd.

Completed

Phase 2 of HU-045 in Glabellar Lines

Glabellar Lines

Korea, Republic of
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)

United States, Canada
Allergan

Completed

A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Glabellar Lines

United States
AbbVie

Completed

A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines

Glabellar Lines

United States
Medytox Korea

Completed

A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

Frown Lines

United States, Canada
Ipsen

Completed

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines (BTX-A-HAC NG)

Moderate to Severe Glabellar Lines

France, Germany
Ipsen

Completed

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

Glabellar Lines

France, Germany, United Kingdom
Ipsen

Completed

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Glabellar Frown Lines

Germany, France
BMI Korea

Completed

Treatment of Moderate to Severe Glabellar Lines (BMI2006) (BMI2006)

Glabellar Lines

Korea, Republic of
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Subject Satisfaction With AbobutulinumtoxinA Treatment (DREAM)

Glabellar Frown Lines

United States
Mohamed Hayder Oleish Salih

Completed

Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique

Glabellar Frown Lines | Wrinkle | Facial Expression | Rhytides

Egypt
Galderma R&D

Completed

A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines

Glabellar Frown Lines

Sweden
Galderma R&D

Completed

Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines

Wrinkles | Glabellar Lines

United States
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines. (ULTRA II)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Germany
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States, Canada
Revance Therapeutics, Inc.

Completed

Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States, Canada
Medytox Korea

Completed

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Hugel

Completed

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Glabellar Lines

Korea, Republic of
Hugel
Sihuan Pharmaceutical Limited

Completed

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Glabellar Lines

Korea, Republic of
Croma-Pharma GmbH

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II (BLESS-II)

Glabellar Frown Lines
Croma-Pharma GmbH

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I (BLESS I)

Glabellar Frown Lines
Hugel

Completed

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Skin Aging

Korea, Republic of
Protox Inc.

Completed

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Croma-Pharma GmbH

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII) (BLESSIII)

Glabellar Frown Lines

United States
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines

Glabellar Lines

United States, Germany, Canada
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Glabellar Frown Lines

Australia
Croma-Pharma GmbH
Hugel

Completed

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines (H2H)

Frown Lines

United States, Austria, Canada
Medy-Tox

Completed

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Medy-Tox

Unknown

Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®

Glabellar Frown Lines

Korea, Republic of

3

Subscribe